Establishment of the cells useful for murine interleukin-18 bioassay by introducing murine interleukin-18 receptor cDNA into human myelomonocytic KG-1 cells

We genetically engineered human myelomonocytic KG-1 cells by introducing cDNA of murine interleukin-18 receptor (MuIL-18R) and established human cells which were capable of responding to MuIL-18. These cells expressed larger number of MuIL-18R (>13,000 sites/cell) than intrinsic human IL-18 recep...

Full description

Saved in:
Bibliographic Details
Published inJournal of immunological methods Vol. 217; no. 1; pp. 97 - 102
Main Authors Taniguchi, Mutsuko, Nagaoka, Katsue, Ushio, Shimpei, Nukada, Yoshiyuki, Okura, Takanori, Mori, Tsutomu, Yamauchi, Hiroshi, Ohta, Tsunetaka, Ikegami, Hakuo, Kurimoto, Masashi
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.08.1998
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We genetically engineered human myelomonocytic KG-1 cells by introducing cDNA of murine interleukin-18 receptor (MuIL-18R) and established human cells which were capable of responding to MuIL-18. These cells expressed larger number of MuIL-18R (>13,000 sites/cell) than intrinsic human IL-18 receptor (HuIL-18R) (<2,500 sites/cell). And the cells responded to MuIL-18 as well as to HuIL-18 in a dose-dependent manner, and produced large amounts of interferon-γ (IFN-γ). We could estimate the amount of murine IL-18 based on the amounts of IFN-γ produced by these cells. The stoichiometry was observed up to 150 ng/ml of MuIL-18. By using these cells, a large amount of MuIL-18 (448±89.2 ng/ml) was detected in sera of Propionibacterium acnes ( P. acnes)/lipopolysaccharide (LPS)-treated endotoxic mice (the same conditions in which IL-18 was first identified). These cells provide us with a useful tool for determining the bioactivity of MuIL-18.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1759
1872-7905
DOI:10.1016/S0022-1759(98)00098-2